Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 800 results for "continuous renal replacement therapy"

Adverse Events Common During Continuous Renal Replacement Therapy
Renal & Urology News

Higher colistin dose during continuous renal replacement thera...

We read with great interest the comments of Rocco and colleagues on colistin dosing in a recent letter in Critical Care [ 1 ]. The application of continuous renal replacement therapy (CRRT) indeed offers an opportunity to prescribe ... Critical Care, 3 weeks ago

16 images for continuous renal replacement therapy

Therapeutic Apheresis and Dialysis, 1 month ago
Renal & Urology News, 2 months ago
MDLinx, 4 days ago
MDLinx, 2 weeks ago
Renal & Urology News, 4 weeks ago
Renal & Urology News, 2 months ago
NewsReality.com, 2 months ago
MDLinx, 2 months ago
CBC, 2 months ago
Blood Purification, 2 months ago

Tedizolid Adsorption and Transmembrane Clearance during in vitro Continuous Renal Replacement Therapy

General Please address all your queries or problem reports to the Pay-per-View Customer Service at ppv@karger.com referring to PPV or PPV account. 1. All payments are by credit card only. The transaction is secure: standard-procedure SSL or ...
 Blood Purification1 week ago

Improved Structure and Function in Autosomal Recessive Polycystic Rat Kidneys with Renal Tubular Cell Therapy

Abstract Autosomal recessive polycystic kidney disease is a truly catastrophic monogenetic disease, causing death and end stage renal disease in neonates and children. Using PCK female rats, an orthologous model of autosomal recessive polycystic ...
 Plosone.org4 days ago
TheStreet.com

Merck and Dynavax Announce New Collaboration Investigating the Combination of Immuno-Oncology Therapies

Merck ( NYSE:MRK ), known as MSD outside the United States and Canada, and Dynavax Technologies Corporation ( Nasdaq: DVAX ) today announced they have entered into two clinical trial collaboration agreements to investigate the ...
 RCL Advisors1 month ago FDA Accepts Supplemental Biologics License Application (sBLA) for KEYTRUDA® (pembrolizumab), Merck's Anti-PD-1 Therapy, in Advanced Non-Small Cell Lung Cancer, and Grants Priority Review  Pharma Voice1 month ago Merck & Co. Release: New Findings Show Durable Anti-Tumor Activity With KEYTRUDA (Pembrolizumab), s Anti-PD-1 Therapy, In Patients With Advanced Head And Neck Cancer, Regardless Of PD-L1 Expression Status  BioSpace1 month ago MERCK : FDA Accepts Supplemental Biologics License Application (sBLA) for KEYTRUDA® (pembrolizumab), Merck's Anti-PD-1 Therapy, in Advanced Non-Small Cell Lung Cancer, and Grants Priority Review  4 Traders1 month ago
[x]  

MESOBLAST : Positive Diabetic Nephropathy Trial Results

POSITIVE TRIAL RESULTS OF MESOBLAST CELL THERAPY IN PATIENTS WITH DIABETES AND ADVANCED CHRONIC KIDNEY DISEASE New York; USA; and Melbourne, Australia; 9 June 2015: Mesoblast Limited (ASX:MSB; USOTC: MBLTY) today announced that results from the ...
 4 Traders4 weeks ago Postive Trial Results Of Mesoblast Cell Therapy In Patients With Diabetes And Advanced Chronic Kidney Disease  Pettinga Financial Advisors4 weeks ago
[x]  

Rockwell Medical Announces Triferic Receives Q-Code Assignment for Product Reimbursement

GlobeNewswire 2015-06-01 Code Q9976 Will Facilitate Reimbursement for Innovative Iron Replacement Drug WIXOM, Mich., June 1, 2015 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq:RMTI), a fully-integrated ...
 BizWire Express1 month ago Rockwell Medical : Announces Triferic Clinical Data Selected for Four Presentations at the 52nd ERA-EDTA Congress May 28-31, 2015 in London, UK  4 Traders1 month ago
[x]  

Multidisciplinary guidelines

MIL OSI Source: Australian Therapeutic Goods Administration Press Release/Statement: Headline: To search for a guideline by key word on this page, use your browser's Find function (Control-F or Edit, Find in most browsers). Please note: ...
 Foreign Affairs.co.nz4 days ago

Data on Candidiasis Discussed by Researchers at University Hospital (EPICO 2.0 PROJECT. Development of educational therapeutic recommendations using...

Data on Candidiasis Discussed by Researchers at University Hospital (EPICO 2.0 PROJECT. Development of educational therapeutic recommendations using the DELPHI technique on invasive candidiasis in critically ill adult patients in special ...) By ...
 Pharmacy Choice6 days ago

Judge orders NHS trust to continue treating man with profound disorder of consciousness

:07 A Court of Protection judge has rejected an NHS trust's application for permission to discontinue life-sustaining treatment for a man in his 40s who was left with a disorder of consciousness following a cardiac arrest. The man, P, ...
 Public Law Today1 week ago

Extending access with long-acting antiretroviral therapy: the next advance in HIV-1 therapeutics and prevention......Current state and limitations of daily oral therapy for treatment

"Two antiretroviral agents amenable to intramuscular or subcutaneous dosing are furthest along in clinical development: rilpivirine, a non-nucleoside reverse transcriptase inhibitor that, in its oral formulation, has been approved for the treatment ...
 National AIDS Treatment Advocacy Project1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less